Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Production & Manufacturing
Fine & Speciality Chemicals
Return to: PBR Home | Production & Manufacturing | Fine & Speciality Chemicals

Fine & Speciality Chemicals

Bayer plans to focus entirely on Life Science businesses Bayer intends in the future to focus entirely on the Life Science businesses – HealthCare and CropScience – and float MaterialScience on the stock market as a separate company. In this way Bayer is positioning itself as a world-leading company in the field of human, animal and plant health.
Production & Manufacturing > Fine & Speciality Chemicals > News
CordenPharma agrees to purchase Peptisyntha from Solvay By PBR Staff Writer
International Chemical Investors Group (ICIG) and the Solvay Group have embarked on an agreement, whereby ICIG will purchase Belgium-based Peptisyntha SA, a custom manufacturer of peptides for pharmaceutical use.
Production & Manufacturing > Fine & Speciality Chemicals > News INVISTA, SilicoLife to develop new technologies for bio-derived processes By PBR Staff Writer
INVISTA and SilicoLife, a computational biology company, have collaborated to develop new technologies that facilitate bio-derived processes for the production of industrial chemicals.
Production & Manufacturing > Fine & Speciality Chemicals > News
See more Fine & Speciality Chemicals news

Latest Fine & Speciality Chemicals News and Insight

View all Fine & Speciality Chemicals news or find news targeted to your interests
Almac Explores Interactive Response Technology: An Untapped Source of Historical and Real-Time Data for Risk-Based Monitoring
| By Almac
Risk-based monitoring has attracted the support of a diverse group of organisations in recent years. Regulators have released guidance encouraging the use of risk-based approaches to clinical trial quality, vendors have created technologies to support such methods, and large pharma companies have pooled their resources to drive adoption. Yet, despite this flurry of activity, the industry has overlooked a potentially useful source of real-time and historical data.
Production & Manufacturing > Fine & Speciality Chemicals > White Papers
Almac Presents Modern Perspectives on Peptide Synthesis, an Introduction
| By Almac
The complexity of synthetic peptide products, whether as reagents used in research or as therapeutic APIs, is increasing. As researchers understand more about the biochemical systems which are targeted, and invent ever more sophisticated products, manufacturing methods must keep pace. We look in this article at a number of challenging product classes, the specific problems they present, and potential solutions: Long peptides; Multi-peptide cocktails; Site-specifically modified products.
Production & Manufacturing > Fine & Speciality Chemicals > White Papers
Almac Presents selectAZymeTM for Effective Biocatalysis Solutions
Almac’s biocatalysis expertise ranges from enzyme discovery, evolution and enzyme production to the synthesis of complex chiral intermediates and active ingredients, all based on selectAZymeTM technology.
Production & Manufacturing > Fine & Speciality Chemicals > Case Studies
Almac's Paediatric Drug Product: Development Through to Commercialisation
Almac, in partnership with a US Biotech client and supported by Merz, a world leader in the design and fabrication of stickpack sachet machines has developed a flexible paediatric dosage form consisting of minitablets filled into stickpacks using a robust manufacturing and filling process suitable for routine commercial manufacture.
Production & Manufacturing > Fine & Speciality Chemicals > Case Studies
Almac: Crystallisation of Pharmaceutical Compounds
| By Almac
The Almac Group explores the chemist's role in protecting intellectual property. It provides development and manufacturing services for Active Pharmaceutical Ingredients (APIs) to pharmaceutical industries worldwide. Over the past 40 years, we have made numerous discoveries that have become powerful intellectual properties (IPs) for our customers.
Production & Manufacturing > Fine & Speciality Chemicals > White Papers
Capital Partnerships: Planning for Long-Term Success, by Almac
With significant capital investment in equipment and extensive associated facility modifications, Almac successfully transferred and scaled-up Ironwood Pharmaceuticals’ innovative yet challenging orally delivered peptide product, linaclotide, helping them prepare to meet global demand in multiple territories.
Production & Manufacturing > Fine & Speciality Chemicals > Case Studies
Almac Group Launches Next Generation Temperature Management Software
Innovative ‘TempEZ™’ solution offers unrivalled end-to-end drug product visibility
Production & Manufacturing > Fine & Speciality Chemicals > Press Releases
Almac Group Announces Further Global Expansion as it Secures New Premises in Republic of Ireland
Craigavon based global contract pharmaceutical development and manufacturing organisation, Almac Group, has secured new premises in Dundalk, County Louth to support its ongoing global expansion plans in response to increased client demand.
Production & Manufacturing > Fine & Speciality Chemicals > Press Releases
Johnson Matthey Launches New Online Catalyst Store
West Deptford, N.J. – 11 January 2017, Johnson Matthey (LSE: JMAT), a leading provider of pharmaceutical services, active pharmaceutical ingredients (APIs) and catalyst technologies, is pleased to announce the launch of its new online catalyst store
Production & Manufacturing > Fine & Speciality Chemicals > Press Releases
View all Fine & Speciality Chemicals news or find news targeted to your interests